Graber Tyson E, Freemantle Erika, Anadolu Mina N, Hébert-Seropian Sarah, MacAdam Robyn L, Shin Unkyung, Hoang Huy-Dung, Alain Tommy, Lacaille Jean-Claude, Sossin Wayne S
Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada.
Children's Hospital of Eastern Ontario Research Institute, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada.
J Neurosci. 2017 Sep 20;37(38):9116-9131. doi: 10.1523/JNEUROSCI.0088-17.2017. Epub 2017 Aug 18.
Neuronal mRNAs can be packaged in reversibly stalled polysome granules before their transport to distant synaptic locales. Stimulation of synaptic metabotropic glutamate receptors (mGluRs) reactivates translation of these particular mRNAs to produce plasticity-related protein; a phenomenon exhibited during mGluR-mediated LTD. This form of plasticity is deregulated in Fragile X Syndrome, a monogenic form of autism in humans, and understanding the stalling and reactivation mechanism could reveal new approaches to therapies. Here, we demonstrate that UPF1, known to stall peptide release during nonsense-mediated RNA decay, is critical for assembly of stalled polysomes in rat hippocampal neurons derived from embryos of either sex. Moreover, UPF1 and its interaction with the RNA binding protein STAU2 are necessary for proper transport and local translation from a prototypical RNA granule substrate and for mGluR-LTD in hippocampal neurons. These data highlight a new, neuronal role for UPF1, distinct from its RNA decay functions, in regulating transport and/or translation of mRNAs that are critical for synaptic plasticity. The elongation and/or termination steps of mRNA translation are emerging as important control points in mGluR-LTD, a form of synaptic plasticity that is compromised in a severe monogenic form of autism, Fragile X Syndrome. Deciphering the molecular mechanisms controlling this type of plasticity may thus open new therapeutic opportunities. Here, we describe a new role for the ATP-dependent helicase UPF1 and its interaction with the RNA localization protein STAU2 in mediating mGluR-LTD through the regulation of mRNA translation complexes stalled at the level of elongation and/or termination.
神经元mRNA在被转运到远处的突触位点之前,可以被包装在可逆停滞的多核糖体颗粒中。突触代谢型谷氨酸受体(mGluRs)的刺激会重新激活这些特定mRNA的翻译,以产生与可塑性相关的蛋白质;这是mGluR介导的长时程抑制(LTD)过程中表现出的一种现象。这种可塑性形式在脆性X综合征(一种人类单基因形式的自闭症)中失调,了解停滞和重新激活机制可能会揭示新的治疗方法。在这里,我们证明,已知在无义介导的RNA衰变过程中阻止肽释放的UPF1,对于来自任何性别的胚胎大鼠海马神经元中停滞多核糖体的组装至关重要。此外,UPF1及其与RNA结合蛋白STAU2的相互作用,对于从典型RNA颗粒底物进行适当的转运和局部翻译以及海马神经元中的mGluR-LTD是必需的。这些数据突出了UPF1在调节对突触可塑性至关重要的mRNA的转运和/或翻译方面的一种新的神经元作用,这与其RNA衰变功能不同。mRNA翻译的延伸和/或终止步骤正在成为mGluR-LTD中的重要控制点,mGluR-LTD是一种在严重单基因形式的自闭症——脆性X综合征中受损的突触可塑性形式。因此,破译控制这种可塑性类型的分子机制可能会带来新的治疗机会。在这里,我们描述了ATP依赖性解旋酶UPF1及其与RNA定位蛋白STAU2的相互作用在通过调节在延伸和/或终止水平停滞的mRNA翻译复合物来介导mGluR-LTD中的新作用。